Respiratory Syncytial Virus (RSV) Vaccine Updates in Older Adults and Pregnant Individuals for the 2024-2025 Viral Respiratory Season.
This session will cover the burden of RSV in older adults and children, review the results of Pfizer’s clinical trials for RSV vaccines in older adults and pregnant individuals including safety/efficacy, and provide the updated RSV vaccine CDC recommendations for the 2024-2025 viral respiratory season. Presented by: Robyn Livingston, MD, MPH, CIC Field Medical Director, Vaccines, U.S. Medical Affairs-Pfizer, Inc.
RSV Vaccine Updates
September 26th at 12:00 PM (CT)
Zoom
Target Audience: Prescribing healthcare providers, Non-prescribing health care providers, Formulary Decision Makers, Patient Organizations
Hosted by the Missouri Rural Health Association and presented by Pfizer, this lunch and learn webinar is FREE OF CHARGE
#Webinar#LunchandLearn
#LunchandLearn#Vaccine